Charles River Laboratories Hosts Investor Day; Reaffirms FY2026 Guidance

What Happened

• Charles River Laboratories International, Inc. filed a Form 8‑K on September 24, 2026 to disclose a press release and host an Investor Day beginning at 9:00 a.m. Eastern time that day (webcast at http://ir.criver.com).
• The press release (furnished as Exhibit 99.1) discusses the company’s business strategy (“Pathway to Purpose”), reaffirms its full‑year 2026 guidance, and provides long‑term financial targets through 2030. The slide presentation for the Investor Day is available via the webcast but is not incorporated by reference into the 8‑K.

Key Details

• Investor Day webcast: September 24, 2026 at 9:00 a.m. ET; archived on the company’s Investor Relations site.
• Press release furnished as Exhibit 99.1 to the Form 8‑K (information furnished, not “filed” under Section 18).
• Company reaffirmed its full‑year 2026 guidance and disclosed long‑term targets extending to 2030.
• Disclosure includes customary forward‑looking statement caution referencing risks (including execution of the Pathway to Purpose strategy and the company’s February 18, 2026 Form 10‑K risk factors).

Why It Matters

• Reaffirming full‑year 2026 guidance gives investors confirmation that management expects to meet previously stated near‑term financial goals, which can reduce short‑term uncertainty.
• New long‑term targets through 2030 and the Investor Day presentation provide a roadmap for management’s strategic priorities and expected performance, helping investors evaluate growth expectations.
• The company’s caution on forward‑looking statements reminds investors that these targets are projections, subject to risks described in prior SEC filings.